|
Re: Bloom Burton Slides
|
3
|
Resverlogix Corp.
|
May 02, 2018 04:38PM
|
|
Re: Israeli Researchers Identify COVID-19 Proteins that Damage Blood Vessels.
|
3
|
Resverlogix Corp.
|
Nov 04, 2021 10:35AM
|
|
Re: Beacon report
|
3
|
Resverlogix Corp.
|
Nov 17, 2017 03:07PM
|
|
Re: What am I missing
|
3
|
Resverlogix Corp.
|
Nov 26, 2021 12:14PM
|
|
Re: BET inhibitor and BRD4 papers keep piling up
|
3
|
Resverlogix Corp.
|
Sep 24, 2017 11:23AM
|
|
Re: Epigenetics market size
|
3
|
Zenith Epigenetics
|
Jan 25, 2024 11:48AM
|
|
Re: FDA approves drug that reduces MACE in Diabetes patients (Forbes)
|
3
|
Resverlogix Corp.
|
Jun 15, 2016 09:16AM
|
|
Re: What would an update really tell us?
|
3
|
Resverlogix Corp.
|
Jul 19, 2015 02:20PM
|
|
Financing curiousity
|
3
|
Resverlogix Corp.
|
Jan 26, 2018 09:55AM
|
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
3
|
Zenith Epigenetics
|
Feb 08, 2019 03:26PM
|
|
Liquidity
|
3
|
Zenith Epigenetics
|
Aug 01, 2019 02:15PM
|
|
FDA fast track
|
3
|
Resverlogix Corp.
|
Jul 09, 2015 01:12PM
|
|
GV and BoM
|
3
|
Resverlogix Corp.
|
Sep 01, 2017 05:20PM
|
|
Re: Warning: Long - Thoughts on Management
|
3
|
Resverlogix Corp.
|
Mar 30, 2021 05:31PM
|
|
AGM
|
3
|
Zenith Epigenetics
|
Oct 04, 2021 11:43AM
|
|
Re: Zenith funding???
|
3
|
Zenith Epigenetics
|
Jun 24, 2019 04:43PM
|
|
Re: And we wait.....
|
3
|
Zenith Epigenetics
|
Jan 26, 2018 12:11PM
|
|
Re: Just back from IR,...
|
3
|
Resverlogix Corp.
|
Oct 29, 2019 07:29PM
|
|
Re: zenith trials
|
3
|
Zenith Epigenetics
|
Dec 25, 2022 08:57AM
|
|
Re: RVX_2018_09_12_Trans...
|
3
|
Resverlogix Corp.
|
Sep 18, 2018 02:36PM
|
